Thrombospondin-1 (TSP-1), a matricellular
protein widely acclaimed to be involved in the inhibition of angiogenesis and
tumorigenesis, is synthesized and secreted by many cell types, including osteoblast and
cancer cells.
TSP-1 is highly upregulated during early stage of osteogenesis, whereas it inhibits terminal osteoblast differentiation. Expression of
TSP-1 is downregulated in
cancer cells, and its ectopic expression has been shown to restrain
tumor growth. Transcriptional regulation of
TSP-1 in osteogenesis and
cancer is poorly understood; this prompted us to study its regulation by the two key regulators of the aforementioned processes: Runx2 and Runx3. Through a PCR-based
cDNA subtraction technique, we identified and cloned a
cDNA fragment for mouse
TSP-1, whose expression was dramatically upregulated in response to Runx2 expression in mesenchymal stem cells. Moreover,
TSP-1 expression was considerably reduced in the lung of Runx2 knockout mouse. On the other hand,
TSP-1 gene expression drastically increased at both the transcriptional and translational levels in response to Runx3 expression in B16-F10
melanoma cells. In line with this, Runx2 and Runx3 bound to the
TSP-1 promoter and stimulated its activity. Hence, these results provide first line of evidence that
TSP-1 is a transcriptional target gene of Runx2 and Runx3.